Abstract
Paradoxical bronchoconstriction to β-agonists has been reported previously, and has been attributed to hypotonicity or acidity of solution or to preservatives such as benzalkonium chloride. As both solutions studied were isotonic, of like acidity, and preservative- and additive-free, these factors were not likely to be contributing to the results observed. Paradoxical bronchocontriction to β-agonists is not necessarily a class effect, but can attributed to treatment with one specific agent while not observed with other agents in the class.
- Copyright © 1995 by the American Academy of Pediatrics
Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
PARADOXICAL BRONCHOCONSTRICTION WITH NEBULIZED ALBUTEROL BUT NOT WITH TERBUTALINE
Jump to section
Related Articles
Cited By...
- No citing articles found.